Results 251 to 260 of about 13,440,667 (290)
Some of the next articles are maybe not open access.

Photodynamic Therapy For Non-Melanoma Skin Cancers

Current Cancer Therapy Reviews, 2009
Photodynamic therapy (PDT) consists of topical or systemic delivery of photosensitizing drugs followed by ir- radiation with light. Topical PDT is currently carried out with 5-aminolaevulinic acid (ALA) or methylaminolaevulinate (MAL) both metabolized in the cells to protoporphyrinIX (PpIX), a photosensitizing molecule absorbing visible light.
MONFRECOLA, GIUSEPPE   +2 more
openaire   +3 more sources

Cetuximab in non-melanoma skin cancer

Expert Opinion on Biological Therapy, 2012
Non-melanoma skin cancer (NMSC) has become the most common cancer with squamous cell carcinoma (SCC) as the major cause of morbidity and mortality. REVIEW AREAS COVERED: The chimeric human-mouse monoclonal antibody Cetuximab against epidermal growth factor receptor (EGFR) has been approved for advanced head and neck cancer (HNC).
openaire   +2 more sources

Prevention of non-melanoma skin cancer

Current Oncology Reports, 2001
Basal cell and squamous cell carcinomas comprise the majority of non-melanoma skin cancers. Whereas the incidence of skin cancer is equivalent to that of all other cancers combined, non-melanoma skin cancer receives a disproportionate share of attention because mortality is relatively low. However, the impact on public health is striking.
openaire   +2 more sources

Management of Non-melanoma Skin Cancer

Seminars in Oncology Nursing, 2013
To review types of, and treatment for, non-melanoma skin cancer (NMSC): basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and less common NMSC.Standards of care, dermatology texts, peer-reviewed journals.BCC grows slowly and rarely metastasizes; some BCC subtypes can be aggressive and destructive.
openaire   +3 more sources

Improving detection of non-melanoma skin cancer Non-melanoma skin cancer.

The Practitioner, 2015
Basal cell carcinomas (BCCs) and squamous cell carcinomas (SCCs) are clinically and pathologically distinct and both are locally invasive. However, while BCCs rarely metastasise, SCCs have the potential to do so especially when they arise on the ears or lips. UV radiation is the most important risk factor for non-melanoma skin cancer (NMSC).
Nina, Natafji, Michael J, Tidman
openaire   +1 more source

Non-melanoma skin cancers

Drug Discovery Today: Disease Mechanisms, 2008
This review examines the nature, incidence and molecular pathogenesis associated with non-melanoma skin cancers (NMSC). These comprise the basal cell carcinomas (BCCs), the most frequent though rarely metastasizing skin tumours, the more aggressive squamous cell carcinomas (SCCs), which are a problem especially in immunosuppressed organ transplant ...
Ahmed, A. H.   +4 more
openaire   +4 more sources

Skin cancer: non-melanoma

2016
Non-melanoma skin cancer (NMSC) is the most common malignancy in fair-skinned populations. In Australia, NMSC is four times as common as all other cancers combined, with an incidence of ~1000 per 100 000 person-years. The incidence of NMSC has been gradually rising among Caucasian/white populations over the last few decades.
Diona L. Damian   +4 more
openaire   +1 more source

Non-melanoma Skin Cancer

1997
Non-melanoma skin cancers (NMSC) comprised of basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) are the most common human cancers [14,24,25]. The annual incidence of NMSC is rapidly increasing, with an average increase between 3% and 6% per year in most populations, and has been reported to be almost 1000 per 100000 people in Australia [1 ...
openaire   +1 more source

Non‐melanoma skin cancer

Medical Journal of Australia, 1996
J, Yeatman, R, Marks
  +5 more sources

Non-melanoma Skin Cancer

2023
Agata Rembielak, Luca Tagliaferri
openaire   +1 more source

Home - About - Disclaimer - Privacy